Accord Healthcare
5 products tracked · names used in filings: Accord Healthcare, Accord Healthcare Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 19 Jan 2026🇪🇺 Expected EC decisionestimate
Enzalutamide Accordpharma (enzalutamide): expected EC decision
Estimated as CHMP opinion (2025-11-13) + 67 days, the standard Commission decision period. Not an official date. · Accord Healthcare · source
Thu 13 Nov 2025🇪🇺 CHMP positive opinion
Enzalutamide Accordpharma (enzalutamide): CHMP positive opinion
Accord Healthcare; Generic · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Enzalutamide Accordpharma enzalutamide | Authorised | |
| 🇪🇺 | Tigecycline Accord tigecycline | Application withdrawn | |
| 🇪🇺 | Macitentan AccordPharma macitentan | Authorised | 2025-09-24 |
| 🇪🇺 | Macitentan Accord macitentan | Authorised | 2025-09-24 |
| 🇪🇺 | Dimethyl fumarate Accord dimethyl fumarate | Authorised | 2024-04-22 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.